@article{94d32b39c45e4816a54e87bede005f43,
title = "Diverse tumorigenic consequences of human papillomavirus integration in primary oropharyngeal cancers",
abstract = "Human papillomavirus (HPV) causes 5% of all cancers and frequently integrates into host chromosomes. The HPV oncoproteins E6 and E7 are necessary but insufficient for cancer formation, indicating that additional secondary genetic events are required. Here, we investigate potential oncogenic impacts of virus integration. Analysis of 105 HPV-positive oropharyngeal cancers by whole-genome sequencing detects virus integration in 77%, revealing five statistically significant sites of recurrent integration near genes that regulate epithelial stem cell maintenance (i.e., SOX2, TP63, FGFR, MYC) and immune evasion (i.e., CD274). Genomic copy number hyperamplification is enriched 16-fold near HPV integrants, and the extent of focal host genomic instability increases with their local density. The frequency of genes expressed at extreme outlier levels is increased 86-fold within ±150 kb of integrants. Across 95% of tumors with integration, host gene transcription is disrupted via intragenic integrants, chimeric transcription, outlier expression, gene breaking, and/or de novo expression of noncoding or imprinted genes. We conclude that virus integration can contribute to carcinogenesis in a large majority of HPV-positive oropharyngeal cancers by inducing extensive disruption of host genome structure and gene expression.",
author = "Symer, {David E.} and Keiko Akagi and Geiger, {Heather M.} and Yang Song and Gaiyun Li and Emde, {Anne Katrin} and Weihong Xiao and Bo Jiang and Andr{\'e} Corvelo and Toussaint, {Nora C.} and Jingfeng Li and Amit Agrawal and Enver Ozer and El-Naggar, {Adel K.} and Zoe Du and Shewale, {Jitesh B.} and Birgit Stache-Crain and Mark Zucker and Nicolas Robine and Coombes, {Kevin R.} and Gillison, {Maura L.}",
note = "Funding Information: We thank the patients with oropharyngeal cancers at Ohio State University (OSU) who enrolled in our research study; members of the Gillison and Symer laboratories for insightful comments; Elisa Venturini, Karen Bunting, Benjamin Hubert, and Dayna M. Oschwald for project management at New York Genome Center; the Genomics Shared Resource at OSU Comprehensive Cancer Center (OSUCCC) for DNA and RNA quality assays; and Jordan Pietz (MD Anderson Cancer Center [MDACC]) for help with graphical figures. This study was funded by the Oral Cancer Foundation (M.L.G.); OSUCCC (M.L.G., D.E.S.); University of Texas MDACC (M.L.G., D.E.S.); Ohio Supercomputer Center (PAS0425, D.E.S.); Ohio Cancer Research Associate grant (GRT00024299, K.A.); Cancer Prevention Research Institute of Texas (CPRIT, RR170005, M.L.G.); and National Cancer Institute grant R50CA211533 (K.A.). Dr. Gillison is a CPRIT Scholar in Cancer Research. D.E.S. would like to dedicate this study to the memory of his father, Donald G. Symer, who died of COVID-19 during the preparation of this manuscript. Publisher Copyright: {\textcopyright} 2022 Symer et al.",
year = "2022",
month = jan,
doi = "10.1101/GR.275911.121",
language = "English (US)",
volume = "32",
pages = "55--70",
journal = "Genome Research",
issn = "1088-9051",
publisher = "Cold Spring Harbor Laboratory Press",
number = "1",
}